Eva Fhärm

Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial

Ulf Näslund, Nawi Ng, Anna Sofia Lundgren et al. · The Lancet · 2018 · 215 citations

Medicine, Cardiology, Preventive Medicine +14

Lifestyle factors and mortality risk in individuals with diabetes mellitus: are the associations different from those in individuals without diabetes?

Diewertje Sluik, Heiner Boeing, Kuanrong Li et al. · Diabetologia · 2013 · 70 citations · Full text

Medicine, Preventive Medicine, Diabetology +11

Change in lifestyle behaviors and diabetes risk: evidence from a population-based cohort study with 10 year follow-up

Adina L. Feldman, Gráinne H. Long, Ingegerd Johansson et al. · International Journal of Behavioral Nutrition and Physical Activity · 2017 · 62 citations · Full text

Medicine, Chronic Disease Prevention, Preventive Medicine +17

Impact of weight maintenance and loss on diabetes risk and burden: a population-based study in 33,184 participants

Adina L. Feldman, Simon J. Griffin, Amy L. Ahern et al. · BMC Public Health · 2017 · 60 citations · Full text

Medicine, Chronic Disease Prevention, Preventive Medicine +17

Screening for type 2 diabetes: do screen-detected cases fare better?

Adina L. Feldman, Simon J. Griffin, Eva Fhärm et al. · Diabetologia · 2017 · 45 citations · Full text

Medicine, Community Health, Preventive Medicine +17